Synchroneuron
Latest round
- Series B
Last raised
- Jul 2014
Total raised
- $26M
Investors
- 1
About Synchroneuron
Synchroneuron biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders.
Who invested in Synchroneuron
1 investor across 2 rounds
See all investors in Synchroneuron
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synchroneuron
Who invested in Synchroneuron?
Synchroneuron has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synchroneuron raised?
Synchroneuron has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Synchroneuron last raise money?
Synchroneuron's most recent round on record is a Series B, in Jul 2014.
What does Synchroneuron do?
Synchroneuron biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders.
Where is Synchroneuron headquartered?
Synchroneuron is headquartered in Waltham, US.
Which VCs invest in companies like Synchroneuron?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Synchroneuron's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Synchroneuron? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.